Cannabis
Veltex Corporation Announces the Appointment of Luba Andrus, RPh., M.J. to the Board of Directors
Veltex Corporation – OTC Markets symbol (VLXC) Veltex Corporation (“Veltex”) announces the appointment of Luba Andrus, RPh., M.J. to the Board of Directors.
Luba Andrus has more than 30 years of executive, operational, and retail leadership experience in both the pharmaceutical and cannabis industries, including owning co-founder and principal of two medical marijuana dispensaries in Illinois.
Prior to entering the medical cannabis industry, she owned and operated numerous retail pharmacies which were ultimately sold to a Resurrection hospital system. Later she recognized the growing needs for pharmacy support within the long-term care industry and served as Director of Outpatient Services and then Chief Operating Officer for long-term care pharmacy provider Omnicare. Her responsibilities included quality control, reduction of medication errors, patient safety, and ensuring customer satisfaction. In 2016 she founded Medication Therapy Management, to provide comprehensive educational services specializing in the application of medical cannabis.
Luba serves on the board of directors for several medical cannabis dispensaries, CBD companies and national addiction organizations. She was a member of several pharmaceutical company advisory boards and continues to serve the patient community within various organizations.
A registered pharmacist, Luba earned her pharmacy degree from the University of Illinois College of Pharmacy and a Master of Jurisprudence in Health Law from Loyola University School of Law in Chicago, specializing in eldercare.
“Luba is a pioneer in the behavioral healthcare services industry, and we are excited to welcome her to Veltex’s board of directors,” said Andreas Mauritzson, Veltex’s President and CEO. “We believe her strong experience, especially in the pharmaceutical area of opioid rehabilitation and building a global business will be extremely valuable as Veltex seeks to identify value creation opportunities, achieve outstanding performance and maximize shareholder value.”
“We conducted an exhaustive search for someone who would further strengthen our board’s breadth of talent and background, and we are delighted to have identified such an outstanding individual,” said R. Preston Roberts, Veltex’s chairman. “I’m confident that Luba is going to make an important and positive impact on our company. The addition of Dr. Harry Haroutunian and Luba Andrus as new directors complements our board of directors’ skills and experiences, and we are confident they will provide valuable perspectives as we continue to execute our strategy, drive profitability and enhance value for all Veltex’s shareholders. We look forward to their contributions and are excited they chose Veltex.”
With the appointment of Ms. Andrus, Veltex’s board consists of 7 members, including: R. Preston Roberts, Chairman, Andreas Mauritzson, Dr. Harry Haroutunian, Stephen G. Macklem, Kenneth Demaree and Robert Fletcher.
SOURCE Veltex Corporation
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis2 weeks ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis2 weeks ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis2 weeks ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis2 weeks ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
Cannabis2 weeks ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands